在人体中，舌下、颊部及口服维拉帕米后，以PQ间期和血清浓度作为维拉帕米吸收的指标。 - Suppr | 超能文献

PQ-intervals and serum concentrations as indices of verapamil absorption following sublingual, buccal and per oral administration in man.

作者信息

Woodcock B G, Asthana O P, Wenchel M, Rietbrock N

出版信息

Methods Find Exp Clin Pharmacol. 1983 Oct;5(8):537-41.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

PQ-intervals and serum concentrations as indices of verapamil absorption following sublingual, buccal and per oral administration in man.在人体中，舌下、颊部及口服维拉帕米后，以PQ间期和血清浓度作为维拉帕米吸收的指标。

Methods Find Exp Clin Pharmacol. 1983 Oct;5(8):537-41.

2

Verapamil disposition and effect on PQ-intervals after buccal, oral and intravenous administration.维拉帕米经颊、口服和静脉给药后的处置及其对PQ间期的影响。

Arzneimittelforschung. 1984;34(4):498-502.

3

[Pharmacokinetics and pharmacodynamics of verapamil in healthy volunteers after single oral and sublingual administration].[单次口服和舌下给药后维拉帕米在健康志愿者体内的药代动力学和药效学]

Arzneimittelforschung. 1982;32(12):1567-71.

4

Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers.健康志愿者舌下和口服维拉帕米后的药代动力学和药效学

Br J Clin Pharmacol. 1992 Jun;33(6):623-7. doi: 10.1111/j.1365-2125.1992.tb04091.x.

5

Verapamil stereoisomerism: enantiomeric ratios in plasma dependent on peak concentrations, oral input rate, or both.

Clin Pharmacol Ther. 1995 Aug;58(2):174-84. doi: 10.1016/0009-9236(95)90195-7.

6

Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.大鼠口服橙皮苷后维拉帕米的生物利用度提高。

Arch Pharm Res. 2008 Apr;31(4):518-22. doi: 10.1007/s12272-001-1187-4. Epub 2008 May 1.

7

Unexpected effect of verapamil on oral bioavailability of the beta-blocker talinolol in humans.维拉帕米对β受体阻滞剂他林洛尔人体口服生物利用度的意外影响。

Clin Pharmacol Ther. 1999 Mar;65(3):283-90. doi: 10.1016/S0009-9236(99)70107-4.

8

A rabbit model for sublingual drug delivery: comparison with human pharmacokinetic studies of propranolol, verapamil and captopril.舌下给药的兔模型：与普萘洛尔、维拉帕米和卡托普利人体药代动力学研究的比较

J Pharm Sci. 2006 Jan;95(1):37-44. doi: 10.1002/jps.20312.

9

Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil.男性对缓释维拉帕米的清除速度快于女性：口服维拉帕米后性别差异的持续观察。

Clin Pharmacol Ther. 2000 Sep;68(3):286-92. doi: 10.1067/mcp.2000.109356.

10

Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.利福平对维拉帕米肝前代谢和肝脏代谢的差异诱导作用。

Hepatology. 1996 Oct;24(4):796-801. doi: 10.1002/hep.510240407.

引用本文的文献

1

Sublingual and Buccal Delivery: A Historical and Scientific Prescriptive.舌下和颊部给药：历史与科学规范

Pharmaceutics. 2025 Aug 20;17(8):1073. doi: 10.3390/pharmaceutics17081073.

2

Preliminary investigation of the efficacy of sublingual verapamil in the management of acute atrial fibrillation and flutter.舌下含服维拉帕米治疗急性房颤和房扑疗效的初步研究。

Br J Clin Pharmacol. 1994 May;37(5):460-3. doi: 10.1111/j.1365-2125.1994.tb05715.x.